Uric acid changes in urine and plasma: An effective tool in screening for purine inborn errors of metabolism and other pathological conditions

Journal of Inherited Metabolic Disease

Volumn 30, Issue 3, 2007, Pages 295-309

  Simoni, R E ^a   Ferreira Gomes, L N L ^a   Scalco, F B ^a   Oliveira, C P H ^a   Aquino Neto, F R ^a   Costa de Oliveira, M L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ASCORBIC ACID; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DIURETIC AGENT; ESTROGEN; FRUCTOSE; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCOGEN DEBRANCHING ENZYME; GLYCOGEN PHOSPHORYLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LAXATIVE; LEAD; LEVODOPA; PANCREAS EXTRACT; PARATHYROID HORMONE; PROBENECID; PURINE; SALICYLIC ACID DERIVATIVE; SULFINPYRAZONE; TAMM HORSFALL GLYCOPROTEIN; THYROID HORMONE; TRIACYLGLYCEROL; UNINDEXED DRUG; URATE; URIC ACID; WARFARIN;

ACUTE CORONARY SYNDROME; ALCOHOL LIVER CIRRHOSIS; ALZHEIMER DISEASE; ATHEROSCLEROSIS; AUTISM; AUTOMUTILATION; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIUM CONTAMINATION; BARTTER SYNDROME; CHRONIC KIDNEY FAILURE; CYSTIC FIBROSIS; DIABETES INSIPIDUS; DIABETIC KETOACIDOSIS; DIETARY INTAKE; DISORDERS OF PURINE AND PYRIMIDINE METABOLISM; DOWN SYNDROME; DRUG MEGADOSE; FAILURE TO THRIVE; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 3; GLYCOGEN STORAGE DISEASE TYPE 5; GLYCOGEN STORAGE DISEASE TYPE 7; GOUT; HEMOLYTIC ANEMIA; HEREDITARY FRUCTOSE INTOLERANCE; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPERURICOSURIA; HYPOPHOSPHATEMIA; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LACTIC ACIDOSIS; LEAD POISONING; LESCH NYHAN SYNDROME; LIVER CIRRHOSIS; METABOLIC SYNDROME X; MYELOPROLIFERATIVE DISORDER; OBESITY; PAGET BONE DISEASE; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PERNICIOUS ANEMIA; PREECLAMPSIA; PSORIASIS; PURINE METABOLISM; RECURRENT INFECTION; REVIEW; RHABDOMYOLYSIS; SARCOIDOSIS; SICKLE CELL ANEMIA; SIDE EFFECT; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION;

BIOLOGICAL MARKERS; DIABETES INSIPIDUS; FEMALE; HUMANS; KIDNEY DISEASES; METABOLISM, INBORN ERRORS; POLYCYSTIC KIDNEY DISEASES; PRE-ECLAMPSIA; PREGNANCY; PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS; URIC ACID;

EID: 34250005914     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0455-8     Document Type: Review

References (92)

1. Ali M, Rellos P, Cox TM (1998) Hereditary fructose intolerance. J Med Genet 35 (5): 353-365.
2. Baguette C, Vermylen C, Brichard B, et al (2002) Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency. J Pediatr Hematol Oncol 24: 69-71.
3. Becker MA (2001) Hyperuricemia and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2513-2535.
4. Bedir A, Topbas M, Tanyeri F, Alvur M, Arik N (2003) Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 44 (4): 527-536.
5. Berkenbosch JW, Lentz CW, Jimenez DF, Tobias JD (2002) Cerebral salt-wasting syndrome following brain injury in three pediatric patients: Suggestions for rapid diagnosis and therapy. Pediatr Neurosurg 36 (2): 75-79.
6. Bettinelli A, Vezzoli G, Colussi G, Bianchetti MG, Sereni F, Casari G (1998) Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis. J Nephrol 11 (2): 61-69.
7. Bordier L, Blanchard A, Sarret D, Herody M, Nedelec G, Duvic C (2004) Hypouricemia, an old subject and new concepts. Presse Med 33 (8): 555-563.
8. Bruce IN (2000) Hyperuricemia in psoriatric arthritis: Prevalence and associated features. J Clin Rheumatol 6 (1): 6-9.
9. Carbone L, Barrow K (2006) Paget disease. In: eMedicine.com/ (Last updated: 5 December 2006). Available at: http://www.emedicine.com/med/ topic2998.htm. Accessed 20 March 2007.
10. Chen HJ, Yau KIT, Tsai KS (2000) Urinary uric acid/creatinine ratio as an additional marker of perinatal asphyxia. J Formos Med Assoc. 99 (10): 771-774.
11. Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521-1551.
12. Cheong HI, Kang JH, Lee JH, et al (2005) Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr Nephrol 20 (7): 886-890.
13. Chow D, Slipman CW (2006) Paget disease. In: eMedicine.com/ (Last updated: 15 June 2006). Available at: http://www.emedicine.com/pmr/ topic98.htm. Accessed 20 January 2007.
14. Collazos J, Blanco MS, Guerra E, Mayo J, Martinez E (2000) Sequential evaluation of serum urate concentrations in AIDS patients with infections of the central nervous system. Clin Chem Lab Med 38 (12): 1293-1296.
15. Conen D, Wietlisbach V, Bovet P, et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4 (1): 9.
16. Criddle LM (2003) Rhabdomyolysis. Pathophysiology, recognition, and management. Crit Care Nurse 23: 14-30.
17. Cundy T, Hegde M, Naot D, et al (2002) A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11 (18): 2119-2127.
18. Devarajan P, Imam A (2006) Bartter syndrome. In: eMedicine.com/ (Last updated: 17 August 2006). Available at: http://www.emedicine.com/PED/ topic210.htm. Accessed 18 March 2007.
19. Devuyst O, Dahan K, Pirson Y (2005) Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol Dial Transplant 20 (7): 1290-1294.
20. Dhaliwal G, Cornett PA, Tierney LM (2004) Hemolytic anemia. Am Fam Physician 69 (11): 2599-2606.
21. Duran M, Dorland L, Meuleman EEE, Allers P, Berger R (1997) Inherited defects of purine and pyrimidine metabolism: Laboratory methods for diagnosis. J Inherit Metab Dis 20 (2): 227-236.
22. Duran M (2002). Miscellaneous analyses. In: Blau N, Duran M, Blaskovics ME, Gibson KM, eds. Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, 2nd edn. New York: Springer, 45-56.
23. Emmerson BT (1996) The management of gout. N Engl J Med 334 (7): 445-451.
24. Fahlen M, Agraharkar M (2007) Nephropathy, uric acid. In: eMedicine.com/ (Last updated: 1 Februay H007). Available at: http://www.emedicine.com/ med/topic1610.htm. Accessed 20 February 2007.
25. Fathallah-Shaykh S and Diven SC, Xanthinuria. In: eMedicine.com/ (Last updated: 15 August 2006). Available at: http://www.emedicine.com/ped/ topic2452.htm. Accessed 19 February 2007.
26. Fathallah-Shaykh S and Neiberger R (2006b) Uric acid stones. In: eMedicine.com/ (Last uHdated: 6 June 2006). Available at: http://www.emedicine.com/ped/topic2361.htm. Accessed 10 March 2007.
27. Feig DI, Johnson RJ (2003) Hyperuricemia in childhood primary hypertension. Hypertension 42: 247.
28. Fick GM, Gabow PA (1994) Natural history of autosomal dominant polycystic kidney disease. Annu Rev Med 45: 23-29.
29. Giordano N, Santacroce C, Mattii G, Graci S, Amendola A, Gennari C (2001) Hyperuricemia and gout in thyroid endocrine disorders. Clin Exp Rheumatol 19 (6): 661-665.
30. Glycogen Storage Disease Type I (2006) In: Wikipedia. Available at: http://en.wikipedia.org/wiki/Von_Gierke_disease. Accessed 23 January 2007.
31. Golov KG, Ivanov OL, Balkarov IM, Novoselov VS (1994) Clinical significance of hyperuricemia in psoriasis. Klin Med (Mosk) 72 (3): 34-36.
32. Gonzalez-Sicilia L, Garcia-Estan J, Martinez-Blasquez A, Fernandez-Pardo J, Quiles JL, Hernandez J (1997) Renal metabolism of uric acid in type I insulin-dependent diabetic patients: Relation to metabolic compensation. Horm Metab Res 10: 520-523.
33. Hayden MR, Tyagi SC (2004) Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab 1 (1): 10.
34. Hershfield MS, Mitchell BS (2001) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2585-2625.
35. Jinnah HA, Friedmann T (2001) Lesch-Nyhan disease and its variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2537-2570.
36. Johnson JL, Duran M (2001) Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3163-3177.
37. Johnson RJ, Kang D-H, Feig D, et al (2003) Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183.
38. Kang DH, Finch J, Nakagawa T, et al (2004) Uric acid, endothelial dysfunction and pre-eclampsia: Searching for a pathogenic link. J Hypertens 22 (2): 229-235.
39. Lee W-C, Lin H-C, Hou MC, et al (1999) Serum uric acid levels in patients with cirrhosis: A reevaluation. J Clin Gastroenterol 29: 261-265.
40. Liberopoulos E, Miltiadous G, Elisaf M (2002) Case report: Hypouricemia as a marker of a generalized proximal tubule damage in alcoholic patients. Alcohol 37 (5): 472-473.
41. Lieber SC (1997) Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta 257: 59-84.
42. Maesaka JK, Wolf-Klein G, Piccione JM, Ma CM (1993) Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. J Am Geriatr Soc 41: 501-506.
43. Maesaka JK, Gupta S, Fishbane S (1999) Cerebral salt-wasting syndrome: does it exist? Nephron 82: 100-109.
44. Malaga S, Pardo R, Malaga I, Orejas G, Fernandez-Toral J (2005) Renal involvement in Down syndrome. Pediatr Nephrol 20 (5): 614-617.
45. Mayatepek E, Koch HG, Hoffmann GF (1997) Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 20: 842-843.
46. Mayaudon H, Burnat P, Eulry F, et al (1998) Hereditary xanthinuria, rare cause of hypouricacidemia. 2 cases. Presse Med 27 (14): 661-663.
47. Medium Chain Acyl-CoA Dehydrogenase Deficiency (2006) In: Emergency Protocols. Available at: http://www.childrenshospital.org/ newenglandconsortium/NBS/MCADD.htm. Accessed 23 February 2007.
48. Milionis HJ, Liamis GL, Elisaf MS (2002) The hyponatremic patient: A systematic approach to laboratory diagnosis. Can Med Assoc J 166: 1056-1062.
49. Moses S, Hyperuricemia. In: Family Practice Notebook.com/ (Last updated: 24 January 2007). Available at http://www.fpnotebook.com/REN87.htm. Accessed 14 February 2007.
50. Muhle R, Trentacoste SV, Rapin I (2004) The genetics of autism. Pediatrics 113: 472-486.
51. Nagyova A, Sustrova M, Raslova K (2000) Serum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome. Physiol Res 49: 227-231.
52. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336 (17): 1224-1234.
53. Page T, Coleman M (2000) Purine metabolism abnormalities in a hyperuricosuric subclass of Autism. Biochim Biophys Acta 1500: 291-296.
54. Paget Disease Juvenile Type (2005) In: About Rare Diseases. Orpha.net/ (Last updated: 22 Febuary H005). Available at: http://www.orpha.net/ consor/cgi-bin/. Accessed 29 January 2007.
55. Pantoja-Martinez J, Navarro Fernandez-Balbuena C, Gormaz-Moreno M, et al (2004) Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise. Rev Neurol 39: 431-434.
56. Peeters MA, Megarbane A, Cattaneo F, Rethore MO, Lejeune J (1993) Differences in purine metabolism in patients with Down's syndrome. J Intellect Disabil Res 37: 491-505.
57. Perlmutter D, Azevedo RA, Kelly D, Shepherd R, Tasawa Y (2002) Metabolic liver disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 35: S180-186.
58. Pittman JR, Bross MH (1999) Diagnosis and management of gout. Am Fam Physician 59: 1799-1806.
59. Purine and Pyrimidine Disorders: ADA Deficiency (2006) In: ESSPPMM. Available at: http://www.amg.gda.pl/~essppmm/ppd/ppd_pu_ada.html. Accessed 23 November 2006.
60. Purine and Pyrimidine Disorders: APRT Deficiency (2006) In: ESSPPMM. Available at: http://www.amg.gda.pl/~essppmm/ppd/ppd_pu_aort.html. Accessed 23 November 2006.
61. Purine Nucleoside Phosphorylase Deficiency (2006) In: ESSPPMM. Available at: http://www.amg.gda.pl/~essppmm/ppd/ppd_pu_pnp.html. Accessed 23 November 2006.
62. Qazi Y, Lohr JW, Hyperuricemia. In: eMedicine.com/ (Last updated: 22 June 2005). Available at: http://www.emedicine.com/med/topic1112.htm. Accessed 17 December 2006.
63. Raivio KO, Saksela M, Lapatto R (2001) Xanthine oxidoreductase-role in human pathophysiology and in hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2639-2652.
64. Roch-Ramel F, Guisan B (1999) Renal transport of urate in humans. News Physiol Sci 14: 80-84.
65. Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2297-2326.
66. Sabina RI, Holmes EW (2001) Myoadenylate deaminase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2627-2638.
67. Sahota AS, Tischfield JA, Kamatani N, Simmonds HA (2001) Adenine phosphoribosyl-transferase deficiency and 2,8- dihydroxyadenine lithiasis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2571-2584.
68. Sarcoidosis, The Merck Manual of Diagnosis and Therapy (2006). Available at: http://www.merck.com/mrkshared/mmanual/section21/chapter288/ 288a.jsp. Accessed 11 February 2007.
69. Schneider D, Hofmann MT, Peterson JA (2002) Diagnosis and treatment of Paget's disease of bone. Am Fam Physician 65: 2069-2072.
70. Scott JT (1996) Gout: The last 50 years. J R Soc Med 89 (11): 634-637.
71. Simmonds HA, Van Gennip AH (2002) Purine and pyrimidine disorders. In: Blau N, Duran M, Blaskovics ME, Gibson KM. eds. Physiciańs Guide to the Laboratory Diagnosis of Metabolic Diseases, 2nd edn. New York: Springer, 445-466.
72. Simmonds HA, Duley JA, Fairbanks LD, McBride MB (1997) When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications. J Inherit Metab Dis 20: 214-226.
73. Sperling O (2001) Hereditary renal hypouricemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 5069-5083.
74. Springate J, Cerebral salt-wasting syndrome. In: eMedicine.com/ (Last updated: 18 September 2006).HAvailable at: http://master.emedicine.com/ ped/topic354.htm. Accessed 22 January 2007.
75. Steinmann B, Gitzelmann R, Van Den Berghe G (2001) Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1489-1520.
76. Subramanian R, Khardori R (2000) Severe hypophosphatemia. Pathological implications, clinical presentations and treatment. Medicine (Baltimore) 79: 1-8.
77. Tarnopolsky MA, et al (2001) Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J. Physiol 533 (3): 881-885.
78. Tarnopolsky MA (2002) Metabolic myopathies and physical activity. Phys Sportsmed 30: 6.
79. Terai C, Hakoda M, Yamanaka H, et al (1995) Adenine phosphoribosyl-transferase deficiency identified by urinary sediment analysis; cellular and molecular confirmation. Clin Genet 48: 246-250.
80. Terkeltaub R, Bushinski DA, Becker MM (2006) Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel anti hyperuricemic therapeutics. Arthritis Res Ther 8 (Suppl 1): S4.
81. Trave DT, Benavent MM, Ariza CJ (1996) Renal hypouricemia in juvenile diabetes mellitus. An Esp Pediatr 44: 425-428.
82. Van Den Berghe G, Jaeken J (2001) Adenylosuccinate lyase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2653-2662.
83. Van Gennip AH (1999) Defects in metabolism of purines and pyrimidines. Ned Tijdschr Klin Chem 24: 171-175.
84. Vanholder R, Sever MS, Erek E, Lameire N (2000) Rhabdomyolysis. J Am Soc Nephrol 11: 1553-1561.
85. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SRJ (2004) Hyperuricaemia does not impair cardio-vascular function in healthy adults. Heart 90: 155-159.
86. Wannamethee SG (2001) Serum uric acid is not an independent risk factor for coronary heart disease. Curr Hypertens Rep 3: 190-196.
87. Weatherall DJ, Clegg JB, Higgs DR, Wood WG (2001) The Hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 4571-4636.
88. Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A (2001) Urate and arteriosclerosis in primary hyper- parathyroidism. Clin Endocrinol 54: 805-811.
89. Wheeler JG, Kelsey KDM, Eiriksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis. PLoS Med 2: 3.
90. Wu WJ, Huang CH, Chiang CP, Huang CN, Wang CN (1993) Urolithiasis related to laxative abuse. J Formos Med Assoc 92: 1004-1006.
91. Yamasaki T, Hamaguchi T, Nakajima H, Matsuzawa Y (1996) Myogenic hyperuricemia. Nippon Rinsho 54 (12): 3343-3348.
92. Yokogoshi Y, Saito S (1996) Abnormal serum uric acid levels in endocrine disorders. Nippon Rinsho 4: 3360-3363.